ArticleFrontiers in pharmacology2026

Tirzepatide versus other anti-diabetic agents for the prevention of diabetic foot complications in patients with type 2 diabetes.

Chia-Yu Kuo et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.